Wednesday, September 30, 2020 9:51:52 AM
Up 3% today. Was told their analyzer
sales might get a boost due to COVID19?
Anyone following this, how is it a COVID play?
sales might get a boost due to COVID19?
Anyone following this, how is it a COVID play?
Recent DXR News
- Daxor Corporation Receives U.S. Patent for Breakthrough Remote Blood Volume Monitor • GlobeNewswire Inc. • 06/02/2026 12:00:00 PM
- Form NT NPORT-P - EDGAR generated form type for a late filing of a Monthly Portfolio Investments Report on Form N-PORT (Public) • Edgar (US Regulatory) • 06/02/2026 01:48:26 AM
- Form 40-8F-2/A - Application for deregistration [Rule O-2]: [Amend] • Edgar (US Regulatory) • 05/21/2026 07:42:07 PM
- Form 40-17F2 - Certificate of accounting of securities in custody of management investment companies [Rule 17f-2] • Edgar (US Regulatory) • 05/06/2026 03:57:25 PM
- Daxor Leverages MedAxiom CV Transforum Spring’26 to Accelerate Commercial Adoption of Blood Volume Analysis • GlobeNewswire Inc. • 04/28/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 05:54:04 PM
- Daxor Expands Customer Footprint with New BVA Program at High-Volume Ohio Cardiology Center • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form N-CEN/A - Annual Report for Registered Investment Companies: [Amend] • Edgar (US Regulatory) • 04/02/2026 05:35:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 10:28:52 PM
- Form 40-17F2 - Certificate of accounting of securities in custody of management investment companies [Rule 17f-2] • Edgar (US Regulatory) • 03/31/2026 07:39:41 PM
- Daxor’s Blood Volume Analysis Metric Validated as Uniquely Accurate Versus Capillary Leak Indexes in New Clinical Data Presented at SCCM 2026 • GlobeNewswire Inc. • 03/26/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:58:26 PM
- Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions • GlobeNewswire Inc. • 03/17/2026 12:00:00 PM
- Daxor to Debut New Rapid, Portable Blood Volume Analyzer at SCCM 2026 Critical Care Congress • GlobeNewswire Inc. • 03/10/2026 12:00:00 PM
- Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 • GlobeNewswire Inc. • 03/09/2026 12:00:00 PM
- Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders • GlobeNewswire Inc. • 03/03/2026 01:30:00 PM
- Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share • GlobeNewswire Inc. • 03/03/2026 01:00:00 PM
- Form N-CSR - Certified Shareholder Report • Edgar (US Regulatory) • 03/02/2026 09:37:20 PM
- Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business • GlobeNewswire Inc. • 02/10/2026 01:00:00 PM
- Form 40-8F-2 - Application for deregistration [Rule O-2] • Edgar (US Regulatory) • 02/09/2026 09:01:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2026 09:58:54 PM
- Form 424B4 - Prospectus [Rule 424(b)(4)] • Edgar (US Regulatory) • 01/24/2026 02:24:06 AM
